• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

Publications

HomeBlogPublications

Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.

2 March, 2012 775

Comas-Casellas E, Martínez-Barriocanal Á, Miró F, Ejarque-Ortiz A, Schwartz S Jr, Martín M, Sayós J. J Biol Chem. 2012 Mar 23;287(13):9682-93. https://www.ncbi.nlm.nih.gov/pubmed/?term=22291008   Abstract Herein we present the cloning and...

Read more

First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology.

18 February, 2012 736

Sánchez O, Llurba E, Marsal G, Domínguez C, Aulesa C, Sánchez-Durán MA, Goya MM, Alijotas-Reig J, Carreras E, Cabero L. Hum Reprod. 2012 Feb;27(2):358-65. https://www.ncbi.nlm.nih.gov/pubmed/?term=22116949 Abstract BACKGROUND: The risk of...

Read more

Brush border Myosin Ia has tumor suppressor activity in the intestine.

31 January, 2012 861

Mazzolini R, Dopeso H, Mateo-Lozano S, Chang W, Rodrigues P, Bazzocco S, Alazzouzi H, Landolfi S, Hernández-Losa J, Andretta E, Alhopuro P, Espín E, Armengol M, Tabernero J, Ramón Y Cajal S, Kloor M, Gebert J, Mariadason JM, Schwartz S Jr...

Read more

Synthesis and In Vivo Evaluation of the Biodistribution of a F-18-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application

30 January, 2012 863

Simon Guerrero; Jose Raul Herance; Santiago Rojas; Juan F. Mena; Juan Domingo Gispert; Gerardo A. Acosta; Fernando Albericio; Marcelo J. Kogan. BIOCONJUGATE CHEMISTRY. 23 -3, pp. 399 – 408. 03/2012...

Read more

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

15 January, 2012 753

Sarró E, Jacobs-Cachá C, Itarte E, Meseguer A. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275-87. doi: 10.1016/j.taap.2011.11.007. Epub 2011 Dec 3...

Read more

Study of biomaterial-induced macrophage activation, cell-mediated immune response and molecular oxidative damage in patients with dermal bioimplants.

2 January, 2012 655

Sánchez O, Rodríguez-Sureda V, Domínguez C, Fernández-Figueras T, Vilches A, Llurba E, Alijotas-Reig J. Immunobiology. 2012 Jan;217(1):44-53. doi: 10.1016/j.imbio.2011.08.003. Epub 2011 Aug 12. https://www.ncbi.nlm.nih.gov/pubmed/?term=21903293...

Read more

Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles.

16 December, 2011 759

Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes VF. Small. 2011 Dec 16;7(24):3479-86. doi: 10.1002/smll.201101511. Epub 2011 Nov 7...

Read more

Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation

10 December, 2011 658

Botella P, Abasolo I, Fernández Y, Muniesa C, Miranda S, Quesada M, Ruiz J, Schwartz S Jr, Corma A. J Control Release. 2011 Dec 10;156(2):246-57 http://www.sciencedirect.com/science/article/pii/S0168365911004743 Abstract Here we report the...

Read more

Carving at the nanoscale: sequential galvanic exchange and Kirkendall growth at room temperature

9 December, 2011 752

González E, Arbiol J, Puntes VF. Science. 2011 Dec 9;334(6061):1377-80 https://www.ncbi.nlm.nih.gov/pubmed/?term=Carving+at+the+nanoscale%3A+sequential+galvanic+exchange+and+Kirkendall+growth+at+room+temperature   Abstract Shape control of...

Read more

Positron emission tomographic imaging of the cannabinoid type 1 receptor system with [¹¹C]OMAR ([¹¹C]JHU75528): improvements in image quantification using wild-type and knockout mice.

1 December, 2011 1110

Herance R, Rojas S, Abad S, Jiménez X, Gispert JD, Millán O, Martín-García E, Burokas A, Serra MÀ, Maldonado R, Pareto D. Mol Imaging. 2011 Dec;10(6):481-7. https://www.ncbi.nlm.nih.gov/pubmed/22201539 Abstract In this study, we assessed the...

Read more

Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards.

18 November, 2011 773

Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. J Cell Mol Med. 2007 Nov-Dec;11(6):1352-66. doi: 10.1111/j.1582-4934.2007.00068.x. https://www.ncbi.nlm.nih.gov/pubmed/?term=18205705 Abstract Oxidative stress has been implicated as a...

Read more

Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice.

15 November, 2011 672

Grande MT, Pascual G, Riolobos AS, Clemente-Lorenzo M, Bardaji B, Barreiro L, Tornavaca O, Meseguer A, López-Novoa JM. Free Radic Biol Med. 2011 Nov 15;51(10):1831-41...

Read more
…891011-14
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
10 days agoby CIBBIM - Nanomedicine0
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
24 February, 2020by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More